Kingsway Acquires Lobe Miracle® Consumer Care Brand
BRISTOL, Tenn., Feb. 5, 2026 — Kingsway Pharmaceuticals, LLC announced the acquisition of the Lobe Miracle® brand from CCA...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
BRISTOL, Tenn., Feb. 5, 2026 — Kingsway Pharmaceuticals, LLC announced the acquisition of the Lobe Miracle® brand from CCA...
HOBOKEN, New Jersey | December 26, 2025 — Dove, a global personal care leader, has partnered with Bridgerton to...
